Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNYNF) Net Cash Flow (2019 - 2025)

Historic Net Cash Flow for Sanofi (SNYNF) over the last 8 years, with Q4 2025 value amounting to -$9.2 billion.

  • Sanofi's Net Cash Flow rose 1298.98% to -$9.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 billion, marking a year-over-year increase of 12571.73%. This contributed to the annual value of -$11.6 billion for FY2025, which is 88813.66% down from last year.
  • Per Sanofi's latest filing, its Net Cash Flow stood at -$9.2 billion for Q4 2025, which was up 1298.98% from $1.6 billion recorded in Q3 2025.
  • Over the past 5 years, Sanofi's Net Cash Flow peaked at $11.3 billion during Q4 2021, and registered a low of -$13.6 billion during Q4 2023.
  • In the last 5 years, Sanofi's Net Cash Flow had a median value of $2.6 billion in 2021 and averaged $1.4 billion.
  • In the last 5 years, Sanofi's Net Cash Flow surged by 944170022.64% in 2021 and then tumbled by 60500.42% in 2024.
  • Over the past 5 years, Sanofi's Net Cash Flow (Quarter) stood at $11.3 billion in 2021, then decreased by 0.55% to $11.2 billion in 2022, then crashed by 221.46% to -$13.6 billion in 2023, then grew by 22.4% to -$10.6 billion in 2024, then grew by 12.99% to -$9.2 billion in 2025.
  • Its last three reported values are -$9.2 billion in Q4 2025, $1.6 billion for Q3 2025, and $7.9 billion during Q2 2025.